Bolt Biotherapeutics Inc
(BOLT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 7,690 | 7,876 | 5,729 | 1,260 | 231 |
| Gross Profit | 7,690 | 7,876 | 5,729 | 1,260 | 231 |
| Operating Expenses | 80,738 | 84,072 | 96,050 | 94,048 | 49,413 |
| Operating Income | -73,048 | -76,196 | -90,321 | -92,788 | -49,182 |
| Other Income | 9,930 | 6,999 | 2,223 | -5,803 | -11,546 |
| Pre-tax Income | -63,118 | -69,197 | -88,098 | -98,591 | -60,728 |
| Net Income Continuous | -63,118 | -69,197 | -88,098 | -98,591 | -60,728 |
| Net Income | $-63,118 | $-69,197 | $-88,098 | $-98,591 | $-60,728 |
| EPS Basic Total Ops | -33.00 | -36.60 | -47.20 | -59.40 | -577.80 |
| EPS Basic Continuous Ops | -33.06 | -36.60 | -47.16 | -59.40 | -577.81 |
| EPS Diluted Total Ops | -33.00 | -36.60 | -47.20 | -59.40 | -577.80 |
| EPS Diluted Continuous Ops | -33.06 | -36.60 | -47.16 | -59.40 | -577.81 |
| EPS Diluted Before Non-Recurring Items | -32.20 | -36.60 | -47.20 | -59.40 | -445.20 |
| EBITDA(a) | $-73,882 | $-78,835 | $-88,471 | $-88,941 | $-48,537 |